Heartflow, Inc. (HTFL) – What Are Researchers Saying About This Stock?

Shares of Heartflow, Inc. (NASDAQ:HTFL) have been assigned an average recommendation of “Moderate Buy” from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $46.25.

HTFL has been the topic of several research analyst reports. Stifel Nicolaus increased their price target on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th. Morgan Stanley raised their price target on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. Wells Fargo & Company boosted their price objective on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Robert W. Baird set a $45.00 price objective on Heartflow in a report on Friday, August 14th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $45.00 price objective (up from $38.00) on shares of Heartflow in a research report on Friday, August 14th.

Heartflow Stock Performance

Shares of HTFL stock opened at $50.32 on Wednesday. Heartflow has a 52 week low of $20.13 and a 52 week high of $54.32. The stock’s fifty day moving average is $45.96 and its 200-day moving average is $34.82.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The business had revenue of $64.08 million during the quarter. The firm’s revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, analysts predict that Heartflow will post -0.75 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Vikram Verghese sold 16,766 shares of the company’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $50.75, for a total transaction of $850,874.50. Following the transaction, the chief financial officer owned 155,183 shares of the company’s stock, valued at $7,875,537.25. This represents a 9.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 3,890 shares of the firm’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $50.00, for a total value of $194,500.00. Following the completion of the transaction, the chief executive officer owned 321,914 shares in the company, valued at approximately $16,095,700. This represents a 1.19% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 265,205 shares of company stock valued at $12,245,527. Company insiders own 7.70% of the company’s stock.

Institutional Trading of Heartflow

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. XXEC Inc. bought a new stake in Heartflow in the second quarter valued at about $2,524,764,000. Quantinno Capital Management LP bought a new position in Heartflow during the first quarter worth about $1,734,000. Sei Investments Co. boosted its holdings in Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock worth $1,631,000 after buying an additional 51,895 shares during the last quarter. Bank of New York Mellon Corp bought a new position in Heartflow during the second quarter worth about $19,096,000. Finally, Handelsbanken Fonder AB acquired a new position in shares of Heartflow during the 2nd quarter worth about $910,000.

Heartflow Company Profile

HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.

Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient’s coronary arteries and can estimate the impact of blockages on blood flow.